8
7/31/2019 08-31-12 nikon_rd_Q1_5 http://slidepdf.com/reader/full/08-31-12-nikonrdq15 1/8 10
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 1/8
10
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 2/8
The number of IC and LCD steppers/scanners sold is expected to decrease on year due to the
market contraction. But, the newly launched IC stepper/scanner will secure the profitable 2nd
half. The previous forecast is unchanged: year-on-year sales down 15% and income down
41%.
Sales volume forecast is unchanged: however, the assumed exchange rate change forces
downgrading of both sales and operating income amounts. Both sales and income are
expected to improve 23% and 39% on year.
In emerging nations such as Asian countries, the bioscience field strives to expand the share
of biological microscopes for general research and clinical use,
while the industrial
instruments field attempts to capture new demand from car industry, etc. The previous
forecast is unchanged: sales is expected to grow 9% on year with
reduced loss.
11
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 3/8
8.7％ 8.7％ 8.3％
9.7％ 9.1％ 8.8％
6.5％ 6.3％ 5.9％
12
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 4/8
17.2％ 11.9％ 11.9％
units units units
units units units
units units units
units units units
13
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 5/8
14
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 6/8
9.2％ 11.0％ 10.4％
15
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 7/8
－％ －％ －％
16
7/31/2019 08-31-12 nikon_rd_Q1_5
http://slidepdf.com/reader/full/08-31-12-nikonrdq15 8/8
65.0
37.5
43.4
29.7
55.9
0
10
20
30
40
50
60
70
09/3 10/3 11/3 12/3 13/3
Capital
Expenditure
Depreciation
61.4 60.2 60.7
68.7
77.0
0
10
20
30
40
50
60
70
80
09/3 10/3 11/3 12/3 13/3
5.0%
6.0%
7.0%
8.0%
9.0%
10.0%R&D
Ratio of R&D
Est. Est.
17
